Evidence mapPaperPMID 41725629Full record

ReviewFrontiers in clinical diabetes and healthcare2026

Clinical and pathophysiological links between hypoglycemia and cardiovascular risk in type 2 diabetes mellitus.

Lamija Ferhatbegović, Minela Bećirović, Emir Bećirović, Sumeja Sarajlić, Aida Ribić, Asja Šarić, Amir Bećirović, Belma Pojskić

Abstract readReview
In one paragraph

Review in Frontiers in clinical diabetes and healthcare, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lamija FerhatbegovićDepartment of General Internal Medicine, Cantonal Hospital Zenica, Zenica, Bosnia and Herzegovina.
Minela BećirovićClinic for Internal Diseases, University Clinical Center Tuzla, Tuzla, Bosnia and Herzegovina.
Emir BećirovićMedical Faculty, University of Zenica, Zenica, Bosnia and Herzegovina.
Sumeja SarajlićDepartment of General Internal Medicine, Cantonal Hospital Zenica, Zenica, Bosnia and Herzegovina.
Aida RibićDepartment of Pediatrics, General Hospital "Prim.dr. Abdulah Nakaš", Sarajevo, Bosnia and Herzegovina.
Asja ŠarićDepartment of General Internal Medicine, Cantonal Hospital Zenica, Zenica, Bosnia and Herzegovina.
Amir BećirovićClinic for Internal Diseases, University Clinical Center Tuzla, Tuzla, Bosnia and Herzegovina.
Belma PojskićMedical Faculty, University of Zenica, Zenica, Bosnia and Herzegovina.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Severe hypoglycemia increases the risk of cardiovascular disease (CVD) in people with diabetes. Large cohort studies and scientific statements show that severe hypoglycemia is linked to higher rates of coronary heart disease, cardiovascular events, and mortality in both type 1 and type 2 diabetes. This risk is especially high in individuals with significant vascular risk, such as older adults and those with multiple cardiovascular risk factors. Hypoglycemia triggers several pathophysiological changes that increase cardiovascular risk. These include activation of the sympathoadrenal system, promotion of proinflammatory and prothrombotic states, arrhythmogenic changes, and increased hemodynamic stress. Experimental evidence shows that recurrent hypoglycemia worsens microvascular dysfunction and promotes adverse cardiac remodeling, especially in people with diabetes. While the link between hypoglycemia and cardiovascular events is well established, the causality remains debated. Hypoglycemia may directly contribute to cardiovascular disease or indicate underlying vulnerability, especially in patients with advanced disease or comorbidities. Minimizing hypoglycemic episodes is recommended for all patients with diabetes, particularly those with established cardiovascular disease, due to the clear association with adverse outcomes.

Indexed as

autonomic dysfunctioncardiovascular diseasesendothelial dysfunctionhypoglycemiatype 2 diabetes

Identifiers

PMID41725629
PMCPMC12916416

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.